Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |